Venture • Life Science

Eight Roads Invests In Checkmate Pharmaceuticals

On June 15, 2017, private equity firm Eight Roads invested in life science company Checkmate Pharmaceuticals

Investment Context
  • This is Eight Roads’ 44th transaction in the Life Science sector.
  • This is Eight Roads’ 73rd transaction in the United States.
  • This is Eight Roads’ 24th transaction in Massachusetts.
Investment Fate
  • Checkmate Pharmaceuticals was sold to a publicly-traded strategic buyer in 2022 for 250M USD.

Explore All 557 Venture Life Science Deals - Search the Database Free


Investment Summary

Date June 15, 2017
Target Checkmate Pharmaceuticals
Sector Life Science
Investor(s) Eight Roads
Deal Type Venture

Target Company

Checkmate Pharmaceuticals

Cambridge, Massachusetts, United States
Checkmate Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the activation of innate immunity to treat cancer. Checkmate Pharmaceuticals was formed in 2015 and is based in Cambridge, Massachusetts.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

Investor

Eight Roads

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1969
PE ASSETS 11.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.


Deal Context for Investor #
Overall 158 of 293
Sector: Life Science 44 of 73
Type: Venture 137 of 266
State: Massachusetts 24 of 33
Country: United States 73 of 119
Year: 2017 23 of 38
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-06-11 ForceClouds

Beijing, China

ForceClouds develops enterprise software intended to provide simple, safe, efficient and compliant information automation. Its software utilizes custom integration capabilities to streamline sales management, clinical trials, and big data and artificial intelligence. ForceClouds is based in Beijing, China.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-06-19 Unbxd

Bengaluru, India

Unbxd is an eCommerce product discovery platform to help online retailers provide a seamless shopping experience to customers. The company deploys self-learning AI/ML models and advanced algorithms to deliver personal recommendation and merchandising controls. Unbxd is based in Bengaluru, India.

Buy -